Tofupill scientific studies (3)

Study on bone health on 98 menopausal women over a 12 month period

Published report:

Menopause 2003; 10(6) pg 522-525 Authors: I Yoles et al - Tofupill (DT56a) - "A New Phyto-Selective Estrogen Receptor Modulator-like Substance for the Treatment of Postmenopausal Bone Loss" (Journal of the North American Menopause Society)

Published abstract:

Obstetrics & Gynecology 2003; 101 (4S) pg 98-99 Authors: Yoles I, Chayen BA - "Selective Estrogen Receptor Modulation by Tofupill, a Unique Phyto-SERM for Menopausal Treatment"

Presentation in medical congress:

The 84th Annual Meeting of the American Association of Clinical Endocrinologist, Chicago, USA, May 2002

The 51st Annual Meeting of the American College of Obstetricians and Gynecologists (ACOG), New Orleans, USA, April 2003

2nd Croatian-Slovene Symposium on Menopause and Andropause, Plitvice, Croatia, May 2003

ENDO 2004 (The 87th Annual Meeting of the American Endocrine Society, San Diego, USA, June 2005

The 16th Annual Meeting of the North American Menopause Society (NAMS), San Diego, USA, September-October 2005

The Integrative Medicine for the Anti-Aging Conference, W Palm Beach, USA, November 2005

[Note: Tofupill is sold under the name Femarelle in the USA.  DT56a is the scientific name for the unique tofu concentrate.  Reference is made to these names in some reports as well as to the name Tofupill.]

Doctors and other suitably qualified persons may email us for a copy of the studies.